PedAM
Pediatric Disease Annotations & Medicines
| Disease | lupus |
| Phenotype | C0003467|anxiety |
| Sentences | 5 |
| PubMedID- 25861456 | Cognitive impairment (prevalence range 30–80%) and behavioural disturbances (prevalence range 17–75%) including mood disorders and anxiety are common manifestations of neuropsychiatric systemic lupus erythematosus (npsle),1–5 and both demonstrate significant impact on quality of life.67 neuropsychological testing has revealed abnormalities in a wide range of cognitive domains in patients with sle;128–12 however, attribution of neuropsychiatric abnormalities to a pathological mechanism associated with sle is hampered by the confounding influences of medications, infections, comorbid disease, hormonal and metabolic disturbances. |
| PubMedID- 23864877 | Whether depression and anxiety are associated with lupus activity remains debatable. |
| PubMedID- 25295916 | Prevalence and severity of depression and anxiety in patients with systemic lupus erythematosus: an epidemiologic study in iranian patients. |
| PubMedID- 23989737 | Objective the objective of this paper is to investigate health-related quality of life (hrqol), fatigue, anxiety and depression in patients with systemic lupus erythematosus (sle) and higher levels of pain and to compare them to patients with lower levels of pain and controls. |
| PubMedID- 21221690 | The burden of anxiety in patients with systemic lupus erythematosus (sle) compared to those with other inflammatory rheumatological conditions is unclear. |
Page: 1